ProteaseTag® Active Proteinase 3 Immunoassay
Respiratory Inflammatory Diseases
CommercialActive
Key Facts
About ProAxsis
ProAxsis is a UK-based diagnostics company focused on the respiratory disease market. Its core innovation is the ProteaseTag® platform, which enables the specific detection of active protease enzymes, offering a potential 'gold standard' over traditional assays that measure total protein. The company has commercialized several immunoassays and offers contract services, positioning itself as a partner for pharmaceutical development and clinical research in conditions like COPD and cystic fibrosis. It is a portfolio company of the investment group NetScientific plc.
View full company profileTherapeutic Areas
Other Respiratory Inflammatory Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Respiratory Disease Candidates | Evozyne | Pre-clinical |